This progressive loss of methylation with advancing disease stage further underscores the dynamic nature of MFSD12 epigenetic regulation during LIHC progression and suggests that demethylation may be associated with more aggressive tumor behavior. The gene discussed is MFSD12; the disease is neoplasm.